Fetuin-A, a Promising Serum Biomarker for Diagnosis of Non-Alcoholic Fatty Liver Disease (NAFLD)
- Conditions
- Digestive System
- Registration Number
- PACTR202309644280965
- Lead Sponsor
- Benha University Hospitals
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 100
1.a dull or aching pain in the top right of the tummy (over the lower right side of the ribs)
2. extreme tiredness
3.unexplained weight loss
4.weakness
1.Patients below the age of 18.
2.patients with a history of significant alcohol intake exceeding 40 g/d in males and 20 g/d in females over the past 5 years.
3.presence of concomitant hepatitis B and hepatitis C virus infection.
4.patients with symptoms and signs suggesting (hemochromatosis, Wilson’s disease, alpha-one anti-trypsin deficiency and autoimmune hepatitis).
5.patients with hepatobiliary malignancy and pregnant females (unfit for Fibroscan & CAP).
6.Patients who use these medications; steatogenic drugs (amiodarone, valproic acid, antiretroviral drugs, methotrexate, and tetracyclines), or medicines that are used for the management of NAFLD (Vitamin E, metformin, and thiazolidinediones) .
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method